Mannkind Corporation (NASDAQ: MNKD) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT MANNKIND CORPORATION

Mannkind Corporation (NASDAQ: MNKD)
Listen to this Section


$3.48
-0.0450 ( -1.28% ) 486.4K

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Market Data


Open $3.48
Previous Close $3.52
Volume 486.4K
Market Cap $1.04B
Day Range $3.42 - $3.54
52 Week Range $2.23 - $6.51
Shares Outstanding 308.95M
Change % -1.28%
Net Change ▼ -0.0450
Insider Ownership -0.03%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2004
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -2,537,675.00

Date Type Amount Purchased Purchaser
2024-07-17 Sale -800.00 Binder Steven B.
2024-07-17 Sale -5000.00 Castagna Michael
2024-07-17 Sale -3362.00 Singh Sanjay R
2024-07-17 Sale -722.00 Sabella Lauren M
2024-07-17 Sale -12616.00 Thomson David
2024-07-17 Sale -4689.00 Tross Stuart A
2024-05-29 Sale -16151.00 BLANK BURKHARD
2024-05-21 Sale -221480.00 Castagna Michael
2024-05-21 Sale -77420.00 Binder Steven B.
2024-05-21 Sale -77420.00 Thomson David

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 12, 2025
8-k 8K-related 12 Nov 10, 2025
10-q Quarterly Reports 106 Nov 05, 2025
8-k 8K-related 12 Nov 05, 2025
4 Insider transactions 1 Nov 03, 2025
8-k 8K-related 13 Oct 09, 2025
3 Insider transactions 1 Oct 09, 2025
4 Insider transactions 1 Sep 17, 2025
8-k 8K-related 11 Aug 27, 2025
8-k 8K-related 33 Aug 25, 2025

Latest News


× Before browsing our site, please accept our cookies policy